3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
12
Fallopian Tube Neoplasms
8
Sarcoma
2
Neoplasms
2
Neoplasm Metastasis
2
Multi-centric Castleman's Disease
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma, Ewing
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Peritoneal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Cancer Recurrent
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphadenopathy
1
Liposarcoma
1
Leiomyosarcoma
1
Hodgkin Disease
1
Histiocytoma, Malignant Fibrous
1
HIV Infections
1
Gliosarcoma
1
Glioblastoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Endometrial Neoplasms
1
Interventions
Cyclophosphamide
23
Vincristine
16
Prednisone
16
Methotrexate
15
prednylidene
13
deltacortene
13
blinatumomab
13
merphos
12
Specimen Handling
12
Cytarabine
12
N,N-dicyclohexyl-isoborneol-10-sulfonamide
10
Mercaptopurine
10
Doxorubicin
10
Dexamethasone
10
pegaspargase
9
azathiopurine
9
Etoposide
9
Biopsy
9
dexamethasone acetate
8
dexamethasone 21-phosphate
8
auricularum
8
Spinal Puncture
8
Rituximab
8
Calcium Dobesilate
8
venetoclax
7
fludarabine
7
Leucovorin
7
Thioguanine
6
Magnetic Resonance Spectroscopy
6
Daunorubicin
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Burkitt Lymphoma
×
liposomal doxorubicin
×
30 days
×
Clear all
No trials found.